Towarzystwo Funduszy Inwestycyjnych PZU SA’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.6K Hold
160
0.01% 538
2026
Q1
$29.3K Hold
160
0.01% 545
2025
Q4
$28.2K Hold
160
0.01% 567
2025
Q3
$22.4K Sell
160
-450
-74% -$60.8K 0.01% 576
2025
Q2
$76.6K Sell
610
-140
-19% -$17.4K 0.02% 299
2025
Q1
$103K Buy
750
+280
+60% +$40K 0.04% 227
2024
Q4
$71.9K Sell
470
-160
-25% -$27K 0.02% 278
2024
Q3
$122K Buy
630
+105
+20% +$22K 0.04% 176
2024
Q2
$122K Hold
525
0.05% 158
2024
Q1
$113K Hold
525
0.05% 174
2023
Q4
$136K Buy
+525
New +$129K 0.06% 132
2021
Q3
$22.6K Hold
80
0.03% 274
2021
Q2
$27.7K Hold
80
0.03% 222
2021
Q1
$22.4K Hold
80
0.03% 241
2020
Q4
$19.6K Buy
+80
New +$20.6K 0.02% 250

Other funds holding BIIB

Towarzystwo Funduszy Inwestycyjnych PZU SA's BIIB Position: Q2 2026 in Review

Towarzystwo Funduszy Inwestycyjnych PZU SA held its Biogen (BIIB) position steady in Q2 2026 at 160 shares worth $34.6K. The position accounts for 0.01% of the portfolio, ranked #538.

Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in BIIB in Q4 2020 and has held it in 15 quarters since. The position peaked at $136K in Q4 2023. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Towarzystwo Funduszy Inwestycyjnych PZU SA held 160 shares of Biogen worth $34.6K as of Q2 2026.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA left its Biogen share count unchanged in Q2 2026.
  • Biogen made up 0.01% of Towarzystwo Funduszy Inwestycyjnych PZU SA's portfolio in Q2 2026, its #538 holding.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in Biogen in Q4 2020 and has held it in 15 quarters since.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA's Biogen position peaked at $136K in Q4 2023.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Towarzystwo Funduszy Inwestycyjnych PZU SA's 13F filing for Q2 2026, filed 7 Aug 2026.